Medical Device Human Factors
Why Companies Choose NAMSA
Medtech Companies Supported With Custom Research Projects
Medical Device Usability Projects Completed
Medical Device Clinical and Regulatory Specialists on Staff
Panel of HCP and Administrator Participants in Our Global Database
The Importance of Human Factors in Medical Device Development
Human factors play a pivotal role in the development of medical devices, ensuring that products are not only functional but also intuitive and user-friendly. By integrating human factors from the early design phase through to post-market modifications, manufacturers can create devices that meet the needs of end-users, enhance safety, and improve overall effectiveness. This user-centered approach helps to:
- Optimize product concept development
- Identify and resolve potential usability issues
- Regulatory compliance and approval
- Deliver products that are both innovative and reliable
This research directly contributes to improving device design, user training, and clinical protocols. When testing is conducted accurately, manufacturers can identify 97% of usability problems.
At NAMSA, we understand the critical importance of human factors and are dedicated to helping you design and test medical devices that truly make a difference.
Key Touch Points in Human Factors Testing
To ensure comprehensive usability and regulatory compliance, human factors may be integrated at various stages of the product lifecycle. The key touch points in which NAMSA can support your human factors testing:
- Early Design Phase: At the outset, our human factors experts collaborate closely with device engineers and human factors designers. This phase involves working with initial product concepts, wireframes, and design sketches to ensure that usability is embedded from the very beginning.
- Prototype Development: Moving forward, Formative Testing sessions are conducted with engineers and potential users. During this stage, we gather invaluable user feedback on prototypes, mock-up devices, and virtual formats, allowing for iterative improvements and refinements.
- Market Approval: As the product nears completion, Summative Testing is carried out with the final end user groups. This rigorous phase includes formal usability testing protocols, multi-angle video recordings, and detailed observations to ensure the device meets all regulatory standards.
- Regulatory Standards:
- Applying Human Factors and Usability Engineering to Medical Devices: FDA Guidance (2016)
- IEC 62366-1: Usability Engineering for Medical Devices
- IEC 14971: Application of Risk Management to Medical Devices
- Post-Market Modifications: Even after a product is launched, human factors remain crucial. We perform testing for device upgrades or changes in claims, collecting user feedback on modifications, usability testing results, and ensuring regulatory compliance checks are met.
Take the Next Step
Want to learn more about our experience in human factors and usability?
Regulatory Requirements for Usability Testing
Human factors and usability testing are essential for ensuring medical devices are safe and effective for their intended users, uses, and environments. The U.S. Food and Drug Administration (FDA) mandates these studies, particularly for high-risk devices where user error could result in significant harm. FDA guidelines highlight the importance of human factors validation studies as part of the pre-market approval process, making usability testing a critical step for manufacturers aiming to bring new products to market.
Beyond FDA requirements, medical device manufacturers must also adhere to other regional regulations, such as the European Union’s Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), as well as Australia’s Therapeutic Goods Administration (TGA). These regulations similarly stress the importance of usability testing to ensure device safety and effectiveness, requiring comprehensive human factors studies throughout the product lifecycle.
At NAMSA, we support compliance with any regulation since we follow international standards and are experts on the details and nuances of global human factors regulatory requirements. Our team ensures that your devices meet all necessary guidelines, facilitating smoother market entry and ensuring the highest standards of safety and usability.
Trust NAMSA to Perform your Human Factor Testing
At NAMSA, we pride ourselves on delivering exceptional human factors and usability testing services for medical devices. Our unique value proposition is built on several key strengths:
- Our ability to deliver creative, cost-effective, and efficient testing solutions tailored to your specific needs
- With a vast network of health care professionals and patients, we ensure rapid and reliable participant recruitment
- Our deep regulatory knowledge guarantees that your products meet all necessary compliance standards, facilitating smoother market entry
- Our collaborative approach and behavioral research skills enable us to provide insightful analysis and actionable recommendations, ensuring your devices are not only compliant but also intuitive and user-friendly
By choosing NAMSA, you gain a partner dedicated to enhancing the safety, effectiveness, and user experience of your medical devices. Our commitment to creativity, regulatory expertise, and collaborative support ensures that your products are not only compliant but also intuitive and user-friendly, making a real difference in the lives of end-users.
Frequently Asked Questions (FAQs)
What level of Human Factors testing does the FDA expect for our device?
FDA expectations depend on your device’s risk profile, intended users, and use environment. NAMSA typically reviews your use‑related risk analysis, device classification, and any prior HF work to determine whether formative studies, a full validation study, or additional justification is needed. They also assess whether your device falls under FDA’s “critical tasks” framework, which drives the depth of testing. The goal is to ensure your HF program aligns with FDA guidance and avoids surprises during review.
How does NAMSA determine the appropriate user groups, environments, and critical tasks?
NAMSA analyzes your device’s intended users, indications for use, and risk profile to define representative user groups and realistic use environments. They review your risk analysis, labeling, and workflow to identify tasks that could lead to harm if performed incorrectly. These become “critical tasks” that must be evaluated in a validation study. NAMSA also considers edge cases—such as low‑literacy users or stressful environments—to ensure the study reflects real‑world use and meets FDA expectations for diversity and realism.
What sample size and recruitment strategy will meet FDA requirements?
Sample size is driven by FDA’s expectation for meaningful representation of each user group, not statistical power. NAMSA typically recommends a minimum of 15 (+1 pilot) participants per user group for validation studies, depending on device complexity and risk. Recruitment focuses on finding participants who genuinely match your intended users in experience, demographics, and training level. NAMSA also ensures that participants are naïve to the device unless real‑world use requires prior training. This approach helps satisfy FDA’s emphasis on realism and user representativeness.
How does NAMSA structure Human Factors documentation to meet FDA submission standards?
NAMSA prepares a Human Factors Validation Report that follows FDA’s recommended structure: device description, user profiles, use environments, risk analysis, formative study summaries, validation study protocol, results, and conclusions. They ensure the narrative clearly links risk‑based decisions to study design and demonstrates that residual use‑related risks are acceptable. The report also includes detailed task analyses, participant demographics, and observed use errors. The goal is to present a coherent, evidence‑based story that shows the device can be used safely and effectively.
What is the expected timeline and cost for Human Factors testing and reporting with NAMSA?
Timelines vary based on device complexity, recruitment difficulty, and the number of study rounds. A typical formative study may take 6–10 weeks, while a full validation study—including protocol development, IRB review if needed, recruitment, testing, and reporting—often spans 12–20 weeks. Costs depend on participant numbers, study locations, and the level of documentation required. NAMSA provides a detailed project plan outlining milestones, dependencies, and budget ranges so you can align HF activities with your regulatory submission strategy.
Meet Our Usability Research Experts
With extensive experience in the medical device industry, we provide guidance on designing and executing studies that meet regulatory standards and drive real-world impact.
Related Services That May Interest You
US FDA Consulting
EU MDR & IVDR Consulting
